Malignant melanoma with metastatic rhabdomyosarcomatoid transdifferentiation [17]

New England Journal of Medicine

Volumn 358, Issue 6, 2008, Pages 649-650

  Gattenlöhner, Stefan ^a   Brocker, Eva Bettina ^a   Muller Hermelink, Hans Konrad ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DACARBAZINE; MELAN A; PROTEIN S 100;

ADULT; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER MORPHOLOGY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CASE REPORT; CERVICAL LYMPH NODE; COMPARATIVE GENOMIC HYBRIDIZATION; GENETIC ANALYSIS; GRANULAR CELL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; LETTER; MALE; MELANOMA; METASTASIS; PHENOTYPE; PRIORITY JOURNAL; RADIATION DOSE; RHABDOMYOSARCOMA; TREATMENT OUTCOME;

EID: 38949120199     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc0707079     Document Type: Letter

References (5)

1. Gattenlöhner S, Marx A, Markfort B, et al. Rhabdomyosarcoma lysis by T cells expressing a human autoantibody-based chimeric receptor targeting the fetal acetylcholine receptor. Cancer Res 2006;66:24-8.
2. Chang ES, Wick MR, Swanson PE, Dehner LP. Metastatic malignant melanoma with "rhabdoid" features. Am J Clin Pathol 1994;102:426-31.
3. Klein WM, Wu BP, Zhao S, Wu H, Klein-Szanto AJ, Tahan SR. Increased expression of stem cell markers in malignant melanoma. Mod Pathol 2007;20:102-7.
4. Weber C, Gokorsch S, Czermak P. Expansion and chondrogenic differentiation of human mesenchymal stem cells. Int J Artif Organs 2007;30:611-8.
5. Peng HQ, Stanek AE, Teichberg S, Shepard B, Kahn E. Malignant rhabdoid tumor of the kidney in an adult: a case report and review of the literature. Arch Pathol Lab Med 2003;127(9):e371-e373.